Abstract
Meningiomas account for about 30% of all intracranial tumors. Evaluation of their proliferation rate is useful for assessing their biological behavior. We evaluated prospectively whether 99mTc-Tetrofosmin (99mTc-TF) uptake in meningiomas correlates with cellular proliferative activity and with tumor grade. We prospectively studied 18 meningioma cases. Brain single-photon emission computed tomography (SPECT) by 99mTc-TF was performed within a week prior to surgical excision. In the excised tumor specimens we assessed Ki-67 antigen expression. 14 of 18 patients had benign meningiomas, while the remaining four had anaplastic meningiomas. A significant correlation was found between both 99mTc-TF uptake and tumor grade (r = 0.722, P = 0.001) and between 99mTc-TF uptake and Ki-67 expression (r = 0.930, P < 0.001). There was a significant correlation between the intensity of tracer uptake and tumor recurrence at 1 year postoperative (r = 0.574, P = 0.02). This pilot study implies that 99mTc-TF brain SPECT could prove useful in differentiating benign from anaplastic meningiomas and is a potential indicator of their proliferative activity.
Similar content being viewed by others
References
Nakasu S, Hirano A, Shimura T et al (1987) Incidental meningiomas at autopsy study. Surg Neurol 27:319–322
Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
Kayaselcuk F, Zorludemir S, Bal N et al (2004) The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neurooncol 67:209–214
Raghavan D, Brecher ML, Johnson DH et al (1999) Textbook of uncommon cancer. Wiley, New York
Onda K, Davis RL, Shibuya M et al (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74:1921–1926
Jaros E, Perry RH, Adam L et al (1992) Prognostic implications of p53 protein, epidermal growth factor receptor and Ki-67 labelling in brain tumours. Br J Cancer 66:373–385
Chen W, Cloughesy T, Kamdar N et al (2005) Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med 46:945–952
Nagashima G, Aoyagi M, Wakimoto H et al (1995) Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478–482
Ohta M, Iwaki T, Kitamoto T et al (1994) MIB1 staining index and scoring of histologic features in meningioma. Cancer 74:3176–3189
Amatya VJ, Takeshima Y, Sugiyama K et al (2001) Immunohistochemical study of Ki-67(MIB-1), p53 protein, p21 WAF1, and p21KIP1 expression in benign, atypical and anaplastic meningiomas. Hum Pathol 32:970–975
Ho DM, Hsu CY, Ting LT et al (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538–1547
Nakaguchi H, Fujimaki T, Matsuno A et al (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254
Kasuya H, Kubo O, Tanaka M et al (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293–296
Smith TA (1998) FDG uptake, tumour characteristics and response to therapy: a review. Nucl Med Commun 19:97–105
Papantoniou VJ, Souvatzoglou MA, Valotassiou V et al (2004) Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res. 6:R56-R62. http://www.breast-cancer-research.com/content/6/2/R56
Denoyer D, Perek N, Le Jeune N et al (2005) Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging 32:820–827
Soricelli A, Cuocolo A, Varrone A et al (1998) Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. J Nucl Med 39:802–805
Choi JY, Kim SE, Shin HJ et al (2000) Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose. J Neurooncol 46:63–70
Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39
Hsu D, Efird J, Hedley Whyte E (1997) Progesterone and estrogen receptors in meningiomas, prognostic considerations. J Neurosurg 86:113–120
Tyagi A, Chakrabarty A, Franks A (2004) MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study. Br J Neurosurg 18:357–361
Shibuya M, Hoshino T, Ito S et al (1992) Meningiomas: clinical implications of a high proliferative potential determined by Bromodeoxyuridine labelling. Neurosurgery 30:494–498
Wakimoto H, Aoyagi M, Nakayama T et al (1996) Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77:373–380
Quiňones-Hinojosa A, Sanai N, Smith JS et al (2005) Techniques to assess the proliferative potential of brain tumors. J Neurooncol 74:19–30
Stemmer-Rachamimov AO, Louis DN (1997) Histopathologic and immunohistochemical prognostic factors in malignant gliomas. Curr Opin Oncol 9:230–234
Di X, Nishizaki T, Harada K, Kajiwara K et al (1997) Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J Exp Clin Cancer Res 16:153–157
Oriuchi N, Tamura M, Shibazaki T et al (1993) Clinical evaluation of thallium-201 SPECT in supratentorial gliomas:relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 34:2085–2089
Prayson R (2005) The Utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms. Adv Anat Pathol 12:144–148
Roser F, Samii M, Ostertag H et al (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37–44
Matsuno A, Fujimaki T, Sasaki T et al (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504–510
Kakinuma K, Tanaka R, Onda K (1998) Proliferative potential of recurrent meningiomas as evaluated by labeling indices of BudR and Ki-67, tumour doubling time. Acta Neurochir (Wien) 140:26–32
Sasaki K, Matsumura K, Tsuji T et al (1988) Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 62:989–993
Lippitz B, Cremerius U, Mayfrank L et al (1996) PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate. Acta Neurochir Suppl 65:108–111
Iuchi T, Iwadate Y, Namba H et al (1992) Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res 21:640–644
Gungor F, Bezircioglu H, Guvenc G et al (2000) Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours. Nucl Med Commun 21:803–810
Tedeschi E, Soricelli A, Brunetti A et al (1996) Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas. Eur J Nucl Med 23:1478–1484
Jinnouchi S, Hoshi H, Ohnishi T et al (1993) Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 34:2091–2094
Platts EA, North TL, Pickett RD et al (1995) Mechanism of uptake of technetium–tetrofosmin. I. Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 2:317–326
Spanu A, Ginesu F, Pirina P et al (2003) The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions. Int J Oncol 22:639–649
Karayalcin U, Ciftci F, Boz A et al (1997) The value of Tc-99 m tetrofosmin thyroid scintigraphy in patients with nodular goiter. Ann Nucl Med 11:285–290
Schillaci O, Danieli R, Romano P et al (2005) Scintimammography for the detection of breast cancer. Expert Rev Med Devices 2:191–196
Perek N, Prevot N, Koumanov F et al (2000) Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines. Nucl Med Biol 27:299–307
Le Jeune N, Perek N, Denoyer D et al (2005) Study of monoglutathionyl conjugates TC-99 M-sestamibi and TC-99 M tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells. Cancer Biot Radiopharm 20:249–259
Le Jeune N, Perek N, Denoyer D et al (2004) Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99 m-sestamibi and Tc-99 m-Tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug resistance MRP1 human glioma cells. Cancer Biother Radiopharm 19:411–421
Alexiou GA, Fotopoulos AD, Papadopoulos A et al (2007) Evaluation of brain tumor recurrence by 99 mTc-Tetrofosmin SPECT: A prospective pilot study. Ann Nucl Med 21:293–298
Alexiou GA, Tsiouris S, Kyritsis AP et al (2007) The use of PET scan in glioblastoma multiforme. J Neurooncol 86:359–360
Alexiou GA, Bokharhii JA, Kyritsis AP et al (2006) Tc-99m Tetrofosmin SPECT for the differentiation of a cerebellar hemorrhage mimicking a brain metastasis from a renal cell carcinoma. J Neurooncol 78:207–208
Alexiou GA, Tsiouris S, Goussia A et al (2008) Evaluation of glioma proliferation by 99mTc-Tetrofosmin. Neuro Oncol 10:104–105
Coons SW, Johnson PC (1993) Regional heter.ogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 52:609–618
Dalrymple S, Parisi JE, Roche PC et al (1993) Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory. Neurosurgery 35:1036–1045
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fotopoulos, A.D., Alexiou, G.A., Goussia, A. et al. 99mTc-Tetrofosmin brain SPECT in the assessment of meningiomas—correlation with histological grade and proliferation index. J Neurooncol 89, 225–230 (2008). https://doi.org/10.1007/s11060-008-9611-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-008-9611-8